Articles from Sanofi Winthrop Industrie

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

 

Chlamydia vaccine candidate granted fast track designation by the US FDA

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

Sanofi successfully prices EUR 1.5 billion of bond issue